The faster way to better drugs
90 % of all clinical studies fail after about 10+ years of expensive development
Even the plain whole blood screening models already enable the discovery of drugs with complex multi-target activities
HOT systems allow an unprecedented characterization of a whole spectrum of bioactivities of drug candidates, compounds and lead substances, enabling an early prediction of relevant primary and secondary drug effects. By means of this a reliable picture of the activity pattern that can be expected to occur in vivo can be obtained already during pre-clinical R&D.
The use of organ-specific co-culture models allows the generation of tissue-specific data.
HOT Screen Culture systems help to reduce attrition rates in the later clinical phases of drug development
Moreover, we provide more than two decades of extensive experience in the critical testing of complex biological materials (natural products, such as herbal extracts, probiotics, etc.)
Read more about our services